Director, ProPath UroDiagnostics

Member, ProPath’s IHC Laboratory and Consultation Services Team

  • Board-certified – Cytopathology and Anatomic and Clinical Pathology by the American Board of Pathology
  • Specialty Training – Genitourinary Pathology, The Johns Hopkins Hospital, Baltimore, under  the direction of Dr. Jonathan Epstein
  • Fellowship – Cytopathology, Memorial Sloan Kettering Cancer Center, NY; and Surgical Pathology, The Johns Hopkins Hospital, MD
  • Residency – Anatomic and Clinical Pathology, The Johns Hopkins Hospital, MD
  • Medical School – University of Illinois College of Medicine, Rockford, IL
  • In addition to urologic pathology, Dr. Oliai also has expertise in immunohistochemistry, specialty testing, surgery center services, and women’s health.
  • Joined ProPath in 2006

Peer-Reviewed Articles

  1. Xu X, Palsgrove D, Kurian E, Yan S, Oliai BR, Bishop JA. Variable expression of S100 protein in sinonasal malignant mucosal melanoma: a potential diagnostic pitfall. Head Neck Pathol. 2020 Apr 1. doi: 10.1007/s12105-020-01158-8. [Epub ahead of print]
  2. Daoud EV, McLean-Holden AC, Pfeifer CM, Timmons CF, Oliai BR, Bishop JA. Pediatric Warthin-like mucoepidermoid carcinoma: report of two cases with one persistent/recurrent as conventional mucoepidermoid carcinoma. Head Neck Pathol. 2020 Mar 27. doi: 10.1007/s12105-020-01156-w. [Epub ahead of print]
  3. Bishop JA, Gagan J, Baumhoer D, McLean-Holden AL, Oliai BR, Couce M, Thompson LDR. Sclerosing polycystic “adenosis” of salivary glands: a neoplasm characterized by PI3K pathway alterations more correctly named sclerosing polycystic adenoma. Head Neck Pathol. 2019 Oct. doi:10.1007/s12105-019-01088-0. [Epub ahead of print]
  4. Kurian EM, Miller R, Mclean-Holden AL, Oliai BR, Bishop JA. Low molecular weight cytokeratin immunostaining for extrafollicular reticulum cells is an effective means of separating salivary gland tumor-associated lymphoid proliferation from true lymph node involvement. Head Neck Pathol. 2019 Sep. doi:10.1007/s12105-019-01080-8.
  5. Shah AA, Oliai BR, Bishop JA. Consistent LEF-1 and MYB immunohistochemical expression in Human papillomavirus-related multiphenotypic sinonasal carcinoma: a potential diagnostic pitfall. Head Neck Pathol. 2019;13(2):220-224.
  6. Weinreb I, Bishop JA, Chiosea SI, Seethala RR, Perez-Ordonez B, Zhang L, Sung YS, Chen CL, Oliai BR, Antonescu CR. Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland. Am J Surg Pathol. 2018;42(4):442-452.
  7. Ghisoli M, Rutledge M, Stephens PJ, Mennel R, Barve, M, Menley M, Oliai BR, Murphy KM, Manning L, Gutierez B, Rangadass P, Walker A, Wang Z, Rao D, Adams N, Wallraven G, Senzer N, Nemunaitis J. Case report: Immune-mediated complete response in a patient with recurrent advanced Ewing sarcoma (EWS) after vigil immunotherapy. J Pediatr Hematol Oncol. 2017;39(4):e183-e186.
  8. Sundarkrishnan L, Bradish JR, Oliai BR, Hosler GA. Cutaneous cellular pseudoglandular schwannoma: an unusual histopathologic variant. Am J Dermatopathol. 2016;38(4):315-318.
  9. Jeung JA, Cao D, Selli BW, Clapp WL, Oliai BR, Parwani AV, Allan RW. Primary renal carcinoid tumors: clinicopathologic features of 9 cases with emphasis on novel immunohistochemical findings. Hum Pathol. 2011;42(10):1554-1561.
  10. Bovio IM, Allan RW, Oliai BR, Hampton T, Rush DS. Xp11.2 translocation renal carcinoma with placental metastasis: a case report. Int J Surg Pathol. 2011;19(1):80-83.
  11. Jenkins CP, Cardona DM, Bowers JN, Oliai BR, Allan RW, Normann SJ. The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction. Arch Pathol Lab Med. 2010;134(2):256-263.
  12. Buresh CJ, Oliai BR, Miller RT. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall. Am J Clin Pathol. 2008;129(6):894-898.
  13. Oliai BR, Sheth S, Burroughs FH, Ali SZ. “Parapharyngeal space” tumors: a cytopathological study of 24 cases on fine-needle aspiration. Diagn Cytopathol. 2005;32(1):11-15.
  14. Oliai BR, Zakowski MF, Lin O. Hodgkin’s lymphoma associated with plasma cell neoplasia: cytological features and review of the literature. Diagn Cytopathol. 2005;33(3):181-186.
  15. Oliai BR, Kahane H, Epstein JI. Can basal cells be seen in adenocarcinoma of the prostate? An immunohistochemical study using high molecular weight cytokeratin (clone 34[beta]E12) antibody. Am J Surg Pathol. 2002;26(9):1151-1160.
  16. Oliai BR, Kahane H, Epstein JI. A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol. 2001;25(6):794-801.
  17. Oliai BR, Tazelaar H, Lloyd R, Doria M, Trastek V. Leiomyosarcoma of the pulmonary veins. Am J Surg Pathol. 1999;23(9):1082-1088.

Book Chapters

  1. Lewin MR, Oliai BR. Immunohistochemistry: background. In: Hosler G, ed. Diagnostic Dermatopathology: A Guide to Ancillary Tests Beyond the H&E. London, England: JP Medical Publishers; 2016:57-60.
  2. Oliai BR, Cohen D. Optimal specimen handling and ancillary studies: renal neoplasia. In: Lager D, Abrahams N, eds. Practical Renal Pathology: A Diagnostic Approach. Philadelphia, PA: Elsevier Saunders; 2013.


  1. Oliai BR, Buresh CJ, Miller RT. Lack of reactivity with TdT in small cell carcinoma [abstract 2077]. Mod Pathol. 2013;26(suppl 2s):499A.
  2. Buresh CJ, Oliai BR, Miller RT. Reactivity with TdT in Merkel cell carcinoma [abstract 407]. Mod Pathol. 2008;21(suppl 1s):91A.
  3. Oliai BR, Kahane H, Epstein JI. A clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy (presentation). USCAP Annual Meeting, Atlanta, GA, 2001.

Our Urologic Pathologists

Bahram Robert Oliai, M.D.

Director, UroDiagnostics

Meet Our Experts

ProPath is an internationally recognized practice of academic-quality expertise with private practices.